DexCom’s Fair Value Estimate has recently been revised downward, moving modestly from $102.08 to $100.54 per share. This change reflects subtle shifts in analyst sentiment. While the company still ...
StockStory.org on MSN
Why DexCom (DXCM) Shares Are Trading Lower Today
Shares of medical device company DexCom (NASDAQ:DXCM) fell 7.4% in the morning session after a short-seller report from Hunterbrook Capital alleged issues with the company's G7 glucose monitoring ...
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $99.3, a high estimate of $106.00, and a low estimate of $89.00. Marking an ...
Fintel reports that on October 1, 2025, Goldman Sachs maintained coverage of DexCom (NasdaqGS:DXCM) with a Buy recommendation ...
DexCom, Inc. (NASDAQ:DXCM) is one of the Best NASDAQ Stocks to Buy with Huge Upside Potential. Wall Street is bullish on DexCom, Inc. (NASDAQ:DXCM) after the company topped revenue and EPS estimates ...
In a report released today, William Plovanic from Canaccord Genuity maintained a Buy rating on Dexcom, with a price target of $106.00. The company’s shares closed last Friday at $67.10. Take advantage ...
We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. DexCom, Inc. is one of them.
Dexcom’s symposium ‘Dexcom CGM Improves Health Outcomes’ will take place on Monday, Sept. 15 at 15:30-16:30 CEST, in Warsaw ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback